Skip to content
  • About Us
    • Company Profile
    • Management
    • Investors
    • Contact
  • Research & Development
    • Mode of Action
    • Clinical Development
    • Publications
  • Vascular Integrity
    • Sepsis & Septic Shock
    • Adrenomedullin
  • News & Events
    • Press releases
    • Media coverage
    • Events
  • Career
  • About Us
    • Company Profile
    • Management
    • Investors
    • Contact
  • Research & Development
    • Mode of Action
    • Clinical Development
    • Publications
  • Vascular Integrity
    • Sepsis & Septic Shock
    • Adrenomedullin
  • News & Events
    • Press releases
    • Media coverage
    • Events
  • Career

Media coverage

Article in ENDPOINTS: Wellington, HBM lead €24M round as Adrenomed preps septic shock treatment for human testing

November 2018 by Amber Tong. Go to the article

Read More »
27. November 2018

Article in SCRIP: Adrenomed Treads A New Path In Septic Shock

by Jo Shorthouse.

Read More »
27. November 2018
Page1 Page2 Page3

Recent News

AdrenoMed Receives FDA Fast Track Designation for Enibarcimab for Treatment of Septic Shock

10. April 2024

Adrenomed to attend San Francisco industry and investor conferences

13. December 2023

Adrenomed presents new findings on its precision medicine treatment for septic shock with enibarcimab during Weimar Sepsis Update

8. September 2023

Adrenomed appoints Dr. Stephan Witte as Chief Medical Officer

1. February 2023

Adrenomed to attend upcoming industry and investor conferences

13. October 2022

Adrenomed appoints David Germonpré as Chief Financial Officer

12. July 2022

More News

Media Coverage

Join the fight against sepsis – invest in life-saving precision medicine at capitalcell.com.

5. February 2025

Article in The Lancet: On the front lines of the sepsis crisis: hurdles faced by sepsis researchers, survivors, and family advocates

19. December 2024

Article in InVivo: End Game: Adrenomed Targets Global Reach For Sepsis Candidate

2. April 2024

Article in MedNous: Adrenomed prepares global study in septic shock

20. March 2023

Article on LaBiotech: Watch: Adrenomed tackling huge issue of sepsis

19. December 2022

Article in GoingPublic’s Plattform Life Sciences: “A phenomenal breakthrough is taking shape”

4. July 2022

Recent Events

J.P. Morgan Week & Biotech Showcase 2025 – Meet us in San Francisco

18. December 2024

2024 World Sepsis Day Symposium

28. August 2024

3CT 2024 – Critical Care Clinical Trialists Workshop

13. June 2024

ISICEM 2024 – International Symposium on Intensive Care & Emergency Medicine

18. March 2024

J.P. Morgan Healthcare Conference & Biotech Showcase 2023 – Meet us in San Francisco

9. January 2023

Adrenomed to attend upcoming industry and investor conferences

13. October 2022
More Events

Archive

  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017

Contact Info

  • +49 (0) 3302 20 77 8 0
  • +49 (0) 3302 20 77 8 15
  • info@adrenomed.com
  • ADRENOMED AG

Neuendorfstraße 15A 
Hennigsdorf b. Berlin 
D-16761, Germany.

Twitter Linkedin
Google Maps

By loading the map, you agree to Google's privacy policy.
Learn more

Load map

PGlmcmFtZSBsb2FkaW5nPSJsYXp5IgoJCQkJCXNyYz0iaHR0cHM6Ly9tYXBzLmdvb2dsZS5jb20vbWFwcz9xPU5ldWVuZG9yZnN0cmElQzMlOUZlJTIwMTVBJTJDJTIwMTY3NjElMjBIZW5uaWdzZG9yZiYjMDM4O3Q9bSYjMDM4O3o9MTUmIzAzODtvdXRwdXQ9ZW1iZWQmIzAzODtpd2xvYz1uZWFyIgoJCQkJCXRpdGxlPSJOZXVlbmRvcmZzdHJhw59lIDE1QSwgMTY3NjEgSGVubmlnc2RvcmYiCgkJCQkJYXJpYS1sYWJlbD0iTmV1ZW5kb3Jmc3RyYcOfZSAxNUEsIDE2NzYxIEhlbm5pZ3Nkb3JmIgoJCQk+PC9pZnJhbWU+

© 2024 AdrenoMed AG | Imprint/Impressum | Legal Notice/Datenschutzerklärung | Expanded Access Policy

Cleantalk Pixel